Karl Barry Sharpless

Karl Barry Sharpless
Born	Karl Barry Sharpless 4/28/1941
Birthplace	Philadelphia, Pennsylvania, U.S.
Nationality	American
Occupation	Chemist
Title	W. M. Keck Professor of Chemistry
Known for	Sharpless epoxidation, Sharpless asymmetric dihydroxylation, click chemistry
Education	Stanford University (PhD, 1968)
Awards	Nobel Prize in Chemistry (2001, 2022), Priestley Medal (2019)

Karl Barry Sharpless (born April 28, 1941) is an American chemist whose contributions to stereoselective chemistry and the development of click chemistry have fundamentally shaped modern organic and pharmaceutical chemistry. Born and raised in Philadelphia, Pennsylvania, Sharpless became only the fifth individual in history—and the second person ever in chemistry—to receive two Nobel Prizes, joining a select company that includes Marie Curie, John Bardeen, Linus Pauling, and Frederick Sanger. He was awarded half of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions and one third of the 2022 Nobel Prize in Chemistry, shared with Carolyn R. Bertozzi and Morten P. Meldal, for the development of click chemistry and bioorthogonal chemistry. Sharpless has spent much of his academic career at the Massachusetts Institute of Technology and the Scripps Research Institute, where he holds the title of W. M. Keck Professor of Chemistry. His research has had far-reaching applications in drug development, materials science, and biomedical research, establishing new paradigms for how chemists construct complex molecules with precision and efficiency.

Early Life

Karl Barry Sharpless was born on April 28, 1941, in Philadelphia, Pennsylvania. He grew up in the Philadelphia area and developed an early interest in science and the natural world. As a young person, Sharpless was drawn to fishing and the outdoors, interests that would later inform his tactile, hands-on approach to laboratory work.

Sharpless's upbringing in the greater Philadelphia region exposed him to the scientific and academic culture of the American Northeast. His formative years coincided with a period of rapid expansion in American science education during the post-war era, which provided expanding opportunities for talented young students interested in the sciences. Sharpless has described his early fascination with the molecular world as something that grew organically from childhood curiosity into a focused academic pursuit.

Education

Sharpless enrolled at Dartmouth College in Hanover, New Hampshire, where he pursued his undergraduate studies. He graduated from Dartmouth in 1963 with a Bachelor of Arts degree. His time at Dartmouth proved formative; Sharpless later credited a Dartmouth professor with helping set the course of his life's work in chemistry. The influence of his undergraduate mentors at Dartmouth helped steer Sharpless toward the study of organic chemistry and stereochemistry, fields in which he would ultimately make his most significant contributions.

Following his undergraduate education, Sharpless moved to Stanford University in California for his graduate studies. At Stanford, he worked under the supervision of Eugene van Tamelen, a distinguished organic chemist. Sharpless completed both his Master of Science and Doctor of Philosophy degrees at Stanford. His doctoral dissertation, completed in 1968, was titled "Studies of the Mechanism of Action of 2,3-oxidosqualene-lanosterol cyclase: Featuring Enzymic Cyclization of Modified Squalene Oxides," and focused on the enzymatic mechanisms underlying the biosynthesis of steroids—work that demonstrated his early interest in stereoselective chemical transformations. The rigorous training Sharpless received at Stanford under van Tamelen provided him with a deep understanding of reaction mechanisms and stereocontrol that would underpin his subsequent career.

Career

Early Academic Career and MIT

After completing his doctorate at Stanford in 1968, Sharpless undertook postdoctoral research before joining the faculty at the Massachusetts Institute of Technology (MIT), where he began to develop his independent research program. At MIT, Sharpless focused on the development of new methods for the selective oxidation of organic molecules, an area that had long been a central challenge in synthetic chemistry. His early work at MIT laid the groundwork for the catalytic asymmetric reactions that would later earn him worldwide recognition.

During his tenure at MIT, Sharpless and his research group made significant advances in understanding how metal catalysts could be used to control the three-dimensional arrangement of atoms in chemical reactions—a concept known as stereoselectivity. This was a period of intense productivity during which Sharpless developed several of the foundational ideas that would define his career.

A safety incident at MIT in 1992 underscored the inherent risks of laboratory chemistry. Sharpless lost the sight in one eye during a laboratory accident, a personal setback that nonetheless did not deter him from continuing his research career at full pace.

Sharpless Epoxidation and Asymmetric Oxidation

Sharpless's most celebrated early contribution to chemistry was the development of what became known as the Sharpless epoxidation, first reported in 1980. This reaction allowed chemists, for the first time, to convert simple organic molecules called allylic alcohols into epoxides—three-membered ring structures containing an oxygen atom—with high levels of enantioselectivity. Enantioselectivity refers to the ability of a chemical reaction to preferentially produce one mirror-image form (or enantiomer) of a product over the other, a critical consideration in pharmaceutical chemistry where the two enantiomers of a drug can have vastly different biological effects.

The Sharpless epoxidation used a titanium-based catalyst in combination with a naturally occurring chiral molecule, diethyl tartrate, to achieve this selectivity. The reaction was notable for its generality—it could be applied to a wide range of substrates—and its practicality, as it employed inexpensive, readily available reagents. The development of this reaction represented a major advance in the field of asymmetric catalysis and had immediate implications for the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals.

Building on the success of the epoxidation reaction, Sharpless subsequently developed the Sharpless asymmetric dihydroxylation, a reaction that converts alkenes into diols (molecules containing two hydroxyl groups) with high enantioselectivity. This reaction employed osmium tetroxide as a catalyst in combination with chiral ligands derived from cinchona alkaloids, and it proved to be one of the most versatile and widely used reactions in asymmetric synthesis. The Sharpless dihydroxylation complemented the epoxidation by providing chemists with another powerful tool for constructing complex molecules with precise three-dimensional control.

Together, the Sharpless epoxidation and asymmetric dihydroxylation transformed the practice of organic synthesis and established Sharpless as one of the foremost synthetic chemists of his generation. These reactions enabled the efficient production of a wide range of biologically active molecules and natural products that had previously been difficult or impossible to synthesize in enantiomerically pure form.

Move to Scripps Research

Sharpless left MIT to join the Scripps Research Institute in La Jolla, California, where he was appointed as the W. M. Keck Professor of Chemistry. At Scripps, Sharpless continued to push the boundaries of synthetic chemistry, expanding his research program to explore new catalytic systems and reaction methodologies. The move to Scripps provided Sharpless with access to an interdisciplinary research environment that fostered collaboration between chemists, biologists, and pharmacologists, broadening the potential applications of his work.

At Scripps, Sharpless continued to refine and extend the applications of his asymmetric oxidation reactions while also beginning to explore entirely new directions in chemical research. His group at Scripps became one of the most productive and influential in all of academic chemistry, attracting talented students and postdoctoral researchers from around the world.

Click Chemistry

In 2001, the same year he received his first Nobel Prize, Sharpless introduced the concept of "click chemistry," a term he coined to describe a philosophy of chemical synthesis emphasizing the use of simple, reliable, and highly selective reactions that proceed rapidly under mild conditions and generate only harmless byproducts. The concept was inspired by nature's own approach to building complex molecules from simple building blocks and represented a departure from the traditional emphasis in organic chemistry on developing increasingly complex and elaborate synthetic strategies.

The most prominent example of a click chemistry reaction is the copper-catalyzed azide-alkyne cycloaddition (CuAAC), which joins an organic azide with a terminal alkyne to form a 1,2,3-triazole linkage. This reaction, developed independently by Sharpless and Morten P. Meldal, proceeds with extraordinary reliability and selectivity in a wide range of solvents, including water, making it suitable for applications in biological systems. The CuAAC reaction became one of the most widely used reactions in chemical biology, materials science, and drug discovery.

Sharpless and his collaborators at Scripps Research continued to develop and expand the click chemistry toolbox over the following two decades. A notable advance was the development of sulfur(VI) fluoride exchange (SuFEx) chemistry, which Sharpless described as a new generation of click reactions. SuFEx reactions involve the exchange of fluoride at sulfur(VI) centers and provide access to a wide variety of sulfonate and sulfamide linkages, expanding the range of molecular architectures that could be assembled using click chemistry principles.

In 2021, Sharpless and his team at Scripps Research were recognized with the Royal Society of Chemistry's Robert Robinson Award in Synthetic Organic Chemistry for their work on three-dimensional click chemistry, acknowledging the breadth and impact of the click chemistry program.

The impact of click chemistry has been immense and wide-ranging. In drug development, click reactions have been used to rapidly assemble libraries of potential drug candidates and to attach therapeutic payloads to targeting molecules. In materials science, click chemistry has enabled the creation of novel polymers, coatings, and functional surfaces. In biomedical research, the reliable and biocompatible nature of click reactions has facilitated the labeling, imaging, and tracking of biomolecules within living cells and organisms. The ongoing applications of click chemistry in areas such as drug delivery, diagnostics, and the study of bacterial membrane permeability continue to demonstrate its utility.

Notable Students

Throughout his career, Sharpless has mentored numerous students and postdoctoral researchers who have gone on to make their own contributions to chemistry. Among his notable doctoral students is M.G. Finn, who has established an independent research career building on the principles of click chemistry and bioconjugation.

Personal Life

Karl Barry Sharpless has maintained a relatively private personal life throughout his career. He lost sight in one eye as the result of a laboratory accident at MIT in 1992, an experience that did not diminish his commitment to experimental chemistry. Sharpless is known among colleagues for his intense focus on molecular problems, his unorthodox thinking, and his willingness to pursue unconventional research directions.

Sharpless has continued to be active in research well into his eighties, maintaining his position at the Scripps Research Institute and continuing to contribute to the development of new click chemistry methodologies.

Recognition

Nobel Prizes

Sharpless received his first Nobel Prize in Chemistry in 2001, sharing half of the prize for his work on chirally catalyzed oxidation reactions. The other half of the 2001 prize was awarded jointly to William S. Knowles and Ryōji Noyori for their work on chirally catalyzed hydrogenation reactions.

In 2022, Sharpless received his second Nobel Prize in Chemistry, sharing the award with Carolyn R. Bertozzi and Morten P. Meldal for the development of click chemistry and bioorthogonal chemistry. The award recognized the transformative impact that click chemistry had exerted on multiple fields of science since its introduction two decades earlier. With this second award, Sharpless became only the fifth individual ever to receive two Nobel Prizes, joining Marie Curie (Physics 1903, Chemistry 1911), Linus Pauling (Chemistry 1954, Peace 1962), John Bardeen (Physics 1956, Physics 1972), and Frederick Sanger (Chemistry 1958, Chemistry 1980). Sharpless is the third person to have been awarded two Nobel Prizes in the same discipline, after Bardeen and Sanger.

Priestley Medal

In 2019, Sharpless was awarded the Priestley Medal, the highest honor bestowed by the American Chemical Society. The award recognized his lifetime of contributions to chemistry, including both his pioneering asymmetric oxidation reactions and his development of click chemistry.

Other Honors

In addition to his Nobel Prizes and the Priestley Medal, Sharpless has received the Robert Robinson Award from the Royal Society of Chemistry in 2021 as part of a collaborative team for work on three-dimensional click chemistry. He has also been the recipient of numerous other awards and honorary degrees throughout his career, reflecting the broad impact of his research across chemistry and related fields.

Legacy

Karl Barry Sharpless's contributions to chemistry span two distinct but interconnected areas: asymmetric catalysis and click chemistry. Each of these research programs has independently transformed the practice of synthetic chemistry and has had lasting consequences for fields ranging from pharmaceutical development to materials science and chemical biology.

The Sharpless epoxidation and asymmetric dihydroxylation reactions, introduced in the 1980s and early 1990s, provided chemists with practical tools for the enantioselective construction of molecules bearing oxygen-containing functional groups. These reactions are now standard methods in the toolkit of synthetic organic chemistry and are routinely employed in the synthesis of drugs, natural products, and other biologically important compounds. The conceptual framework that Sharpless established—using small amounts of a chiral catalyst to control the stereochemical outcome of a reaction—helped catalyze a broader revolution in asymmetric catalysis that has since become one of the defining themes of modern chemistry.

Click chemistry, introduced by Sharpless in 2001, represented an equally significant shift in chemical thinking. By advocating for the use of simple, reliable, and modular reactions, Sharpless challenged the prevailing emphasis in synthetic chemistry on complexity and elegance, arguing instead for practicality and efficiency. The copper-catalyzed azide-alkyne cycloaddition and subsequent SuFEx reactions developed by his group have been adopted by researchers across the natural sciences and engineering, becoming some of the most frequently used reactions in contemporary chemistry. The concept of click chemistry has also influenced thinking about molecular design in drug discovery, where the rapid assembly of molecular libraries has become a standard approach.

The fact that Sharpless achieved recognition at the highest level for two separate bodies of work—reflected in his two Nobel Prizes—places him in an extraordinary position within the history of science. His career illustrates how fundamental research in chemistry can yield practical tools with wide-ranging applications, and his work continues to influence new generations of chemists pursuing challenges in catalysis, synthesis, and chemical biology.